February 7, 2025
Loading...
You are here:  Home  >  Health Care & Life Science  -  Page 143
Latest

Sientra settles lawsuits over public offering

By   /  Friday, November 4th, 2016  /  Health Care & Life Science, Latest news, Technology  /  Comments Off on Sientra settles lawsuits over public offering

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Inogen sales, profits soar in third quarter

By   /  Thursday, November 3rd, 2016  /  Earnings, Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Inogen sales, profits soar in third quarter

Inogen revenues, profits and earnings per share were up for the third quarter, the company announced Nov. 3. Inogen, a Goleta-based manufacturer of direct-to-consumer respiratory products, said revenues increased 33 percent during the quarter from $40.7 million during the same quarter last year to $54.4 million in 2016, which topped analyst revenue estimates of $47.9 Read More →

Latest

Wage, break issues spur class action lawsuits

By   /  Friday, October 28th, 2016  /  Health Care & Life Science, Latest news, Law & Goverment  /  Comments Off on Wage, break issues spur class action lawsuits

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen beats analysts’ revenue, earnings per share estimates

By   /  Thursday, October 27th, 2016  /  Earnings, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen beats analysts’ revenue, earnings per share estimates

Amgen revenues increased 2 percent during the third quarter as it beat analysts’ revenue and earnings per share estimates thanks to cost-cutting measures and lower research measures. Revenues for the Thousand Oaks-based biotech giant increased from $5.72 billion during the third quarter of 2015 to $5.81 billion in 2016, which beat analyst estimates of $5.73 Read More →

Latest

Sientra CFO resigns, new CFO named

By   /  Thursday, October 27th, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on Sientra CFO resigns, new CFO named

Embattled-breast implant manufacturer Sientra said in a news release Oct. 27 that Chief Financial Officer Matthew Pigeon stepped down from his position “to pursue other opportunities.” Patrick Williams, who most recently served as CFO of Pleasanton-based ZELTIQ Aesthetics from November 2012 until this past April, will fill Pigeon’s roll as CFO at Sientra. Williams also Read More →

Latest

Dignity Health plans merger with Catholic Health Initiatives

By   /  Monday, October 24th, 2016  /  Health Care & Life Science, Latest news  /  Comments Off on Dignity Health plans merger with Catholic Health Initiatives

San Francisco-based Dignity Health plans to merge with Colorado-based Catholic Health Initiatives in a deal that would combine a couple of the largest nonprofit providers in the country, Dignity announced on Oct. 24. Dignity Health owns five hospitals in the Tri-Counties, including Arroyo Grande Community Hospital, French Hospital Medical Center in San Luis Obispo, St. Read More →

Latest

Proposition 61 will not cure sky high drug prices

By   /  Friday, October 21st, 2016  /  Editorials, Health Care & Life Science, Latest news, Law & Goverment, Opinion  /  Comments Off on Proposition 61 will not cure sky high drug prices

Proposition 61 goes before California voters in just a few weeks. And as the Business Times reported on Oct. 14, Amgen, the Thousand Oaks-based biotech giant, along with other major drug companies, is spending millions to oppose Proposition 61 and its plan to control drug prices. Proponents promote the David vs. Goliath aspect of their Read More →